Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Metabolic Disorders
4.2.2 Increase in Geriatric Population in Asia Pacific Region
4.2.3 High Spending on Healthcare Along with Rise of Middle-class In Emerging Economies
4.3 Market Restraints
4.3.1 Unwillingness of Hospitals and In-house Pharmacies/ Dispensaries to Maintain the Required Stock of Clinical Nutrition Products
4.3.2 Heterogeneous Nature Of Government Coverage/Reimbursement Across Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Route of Administration
5.1.1 Oral and Enteral
5.1.2 Parenteral
5.2 By Application
5.2.1 Nutritional Support in Malnutrition
5.2.2 Nutritional Support in Metabolic Disorders
5.2.3 Nutritional Support in Gastrointestinal Diseases
5.2.4 Nutritional Support in Neurological Diseases
5.2.5 Nutritional Support in Cancer
5.2.6 Nutritional Support in Other Diseases
5.3 By End User
5.3.1 Pediatric
5.3.2 Adult
5.4 Geography
5.4.1 China
5.4.2 Japan
5.4.3 India
5.4.4 Australia
5.4.5 South Korea
5.4.6 Rest of Asia-Pacific


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Nutrition
6.1.2 Nestle Health Science
6.1.3 Baxter Healthcare
6.1.4 B. Braun Melsungen AG
6.1.5 Nutricia
6.1.6 Mead Johnson
6.1.7 Perrigo Company PLC
6.1.8 Fresenius Kabi


7 MARKET OPPORTUNITIES AND FUTURE TRENDS